ORIC Pharmaceuticals, Inc. (ORIC) Revenue History
Annual and quarterly revenue from 2017 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
ORIC Revenue Growth
ORIC Revenue Analysis (2017–2025)
As of May 8, 2026, ORIC Pharmaceuticals, Inc. (ORIC) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q1 2026) recorded $0 in revenue.
Looking at the longer-term picture, ORIC's historical revenue data shows various trends over time.
When compared to Healthcare sector peers including KYMR (-12.6% YoY), TNGX (+48.3% YoY), and ARVN (-0.3% YoY). Compare ORIC vs KYMR →
ORIC Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| ORICCurrent | $0 | - | - | - | |
 KYMR | $39M | -12.6% | +2.9% | -891.3% | |
 TNGX | $62M | +48.3% | +52.1% | -178.4% | |
 ARVN | $263M | -0.3% | +58.9% | -43.8% |
ORIC Historical Revenue Data (2017–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $-1,220,000 | - | $-143,004,000 | - |
| 2024 | $0 | - | $-1,107,000 | - | $-142,895,000 | - |
| 2023 | $0 | - | $-1,032,000 | - | $-110,780,000 | - |
| 2022 | $0 | - | $0 | - | $-91,767,000 | - |
| 2021 | $0 | - | $0 | - | $-78,871,000 | - |
| 2020 | $0 | - | $0 | - | $-74,186,000 | - |
| 2019 | $0 | - | $-1,000,000 | - | $-28,569,000 | - |
| 2018 | $0 | - | $-900,000 | - | $-22,371,000 | - |
| 2017 | $0 | - | $-900,000 | - | $-22,541,000 | - |
See ORIC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ORIC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ORIC vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonORIC — Frequently Asked Questions
Quick answers to the most common questions about buying ORIC stock.
Is ORIC's revenue growth accelerating or slowing?
ORIC TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is ORIC's long-term revenue growth rate?
ORIC Pharmaceuticals, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is ORIC's revenue distributed by segment?
ORIC reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2017-2025 are available for download. Segment mix reveals concentration and diversification trends.